Cannabinoid receptor mediating iminopyrazole compounds

US10787419B2 · kind B2 · utility

Assignee

• The United States of America, as represented by the Secretary, Department of Health and Human Services · US

Inventors

• George Kunos · Bethesda, US
• Malliga Iyer · Germantown, US
• Resat Cinar · Bethesda, US
• Kenner C. Rice · Bethesda, US

Key dates

• Filing date: Aug 10, 2017
• Grant date: Sep 29, 2020
• Expiry date: Aug 10, 2037

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D417/12
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

A compound, or a pharmaceutically acceptable salt or ester thereof, comprising (i) a CB1 receptor mediating scaffold conjugated to (ii) a second therapeutic scaffold.